First Heartland Consultants’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,902
Closed -$249K 542
2025
Q4
$249K Buy
+3,902
New +$240K 0.02% 466
2022
Q1
Sell
-1,995
Closed -$241 362
2021
Q4
$241 Buy
+1,995
New +$222K 0.01% 321
2021
Q3
Sell
-1,960
Closed -$229K 397
2021
Q2
$229K Hold
1,960
0.03% 346
2021
Q1
$216K Buy
+1,960
New +$213K 0.03% 358
2017
Q4
Sell
-2,965
Closed -$268K 288
2017
Q3
$268K Buy
2,965
+1
+0% +$85 0.07% 284
2017
Q2
$249K Buy
2,964
+85
+3% +$6.85K 0.06% 293
2017
Q1
$233K Buy
+2,879
New +$226K 0.07% 298

Other funds holding EMN

First Heartland Consultants's EMN Position: Q1 2026 in Review

First Heartland Consultants sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 3,902 shares — an estimated $249K sold.

First Heartland Consultants first reported a position in EMN in Q1 2017 and held it in 7 quarters. The position peaked at $268K in Q3 2017. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • First Heartland Consultants reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
  • First Heartland Consultants sold 3,902 Eastman Chemical shares in Q1 2026, an estimated $249K.
  • First Heartland Consultants first reported a position in Eastman Chemical in Q1 2017 and held it in 7 quarters.
  • First Heartland Consultants's Eastman Chemical position peaked at $268K in Q3 2017.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on First Heartland Consultants's 13F filing for Q1 2026, filed 8 Apr 2026.